Serial Number
88189793
Owner
MetiMedi pharmaceuticals Co., LTD.Attorney
N. Christopher NortonFiling Date
Nov 12, 2018
METI MEDI Trademark
Serial Number: 88189793 • Registration: 6077567
Trademark Classes
Owner Contact Info
Suite 908 IBS tower
Incheon 22006 , KR
Entity Type: 03
Legal Representation
Correspondence Address
N. Christopher Norton ArentFox Schiff LLP
1717 K Street, NW
Washington, DC 20006-5344
UNITED STATES
Trademark Details
Filing Date
November 12, 2018
Registration Date
June 16, 2020
Published for Opposition
March 31, 2020
Goods & Services
Anti-cancer preparations; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for immunity adjustment; Vaccines; Pharmaceutical agents for regenerating cells; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemico-pharmaceutical preparations, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Pharmaceuticals for medical purposes for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Antibacterial substances for medical purposes; Antibodies for medical purposes for the treatment of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemical preparations for medical purpose, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic kits for medical diagnostic purposes comprising reagents for use in disease testing, health monitoring and more generally, predictive and preventive medicine in the fields of detecting immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic pharmaceutical preparations for medical purposes; Antibiotics; Tumor suppressing agents; Chemotherapeutics
